Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.090
+0.020 (1.87%)
May 2, 2025, 4:00 PM EDT - Market closed
RANI Employees
As of December 31, 2024, Rani Therapeutics Holdings had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees decreased by 34 or -24.29% compared to the previous year.
Employees
106
Change (1Y)
-34
Growth (1Y)
-24.29%
Revenue / Employee
$9,698
Profits / Employee
-$283,189
Market Cap
62.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 106 | -34 | -24.29% |
Dec 31, 2023 | 140 | -23 | -14.11% |
Dec 31, 2022 | 163 | 49 | 42.98% |
Dec 31, 2021 | 114 | 43 | 60.56% |
Dec 31, 2020 | 71 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
RANI News
- 4 weeks ago - Rani Therapeutics Holdings, Inc. (RANI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102 - GlobeNewsWire
- 5 weeks ago - Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 7 months ago - Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants - GlobeNewsWire
- 7 months ago - Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 8 months ago - Rani Therapeutics to Participate in September Investor Conferences - GlobeNewsWire
- 9 months ago - Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update - GlobeNewsWire